Drug-Resistant Tuberculosis in High-Risk Groups, Zimbabwe
- John Z. Metcalfe
- Salome Makumbirofa
- Beauty Makamure
- Charles Sandy
- Wilbert Bara
- Stanley Mungofa
- Philip C. Hopewell
- Peter Mason
Publication date
January 2014
DOI Publisher
Centers for Disease Control and Prevention (CDC) Journal
Emerging Infectious DiseasesAbstract
To estimate prevalence of multidrug-resistant tuberculosis (MDR TB) in Harare, Zimbabwe, in 2012, we performed microbiologic testing on acid-fast bacilli smear-positive sputum samples from patients previously treated for TB. Twenty (24%) of 84 specimens were consistent with MDR TB. A national drug-resistance survey is needed to determine MDR TB prevalence in Zimbabwe
Add to ORKG